BioCentury
ARTICLE | Company News

Gilead, Aspen Pharmacare sales and marketing update

May 2, 2005 7:00 AM UTC

The companies signed a letter of intent under which Aspen would receive a non-exclusive license to distribute and manufacture GILD's HIV drugs Viread tenofovir and Truvada emtricitabine and tenofovi...